Certara stock.

Or log in with. Google TwitterMar 14, 2023 · Certara, Inc. (CERT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year ... CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth.We would like to show you a description here but the site won’t allow us.

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.

November 15, 2021. PRINCETON, N.J.– November 15, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering by certain selling stockholders of 10 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission.Key Insights Using the 2 Stage Free Cash Flow to Equity, Certara fair value estimate is US$18.83 Certara is estimated... Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Dec 1, 2023 · 8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price. The estimated Net Worth of William F Feehery is at least $78.7 Millón dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Robert has made over 7 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Robert exercised 8,646 units of CERT stock worth $166,436 on 31 March 2023.Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile.

Avatar has made over 8 trades of the Certara stock since 2020, according to the Form 4 filled with the SEC. Most recently Avatar sold 29,954,521 units of CERT stock worth $449,317,815 on 8 December 2022.

The estimated Net Worth of Michael Andrew Schemick is at least $24.7 Million dollars as of 31 March 2023. Michael Schemick owns over 13,302 units of Certara stock worth over $12,184,118 and over the last 4 years …

Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...11 Des 2020 ... The EQT-backed drug simulation software maker's shares jumped as much as 72% following the company's IPO.Nov 23, 2023 · Latest Software and Certara Inc, Blackbaud Inc Stock News. As of November 22, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $426.2 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price ... Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensCertara's software platform Simcyp group awarded two new grants from US FDA Certara downgraded at Jefferies on growth headwinds Certara Non-GAAP EPS of $0.12 misses by $0.01, revenue of $90.45M ...

Stock Price Statistics The stock price has decreased by -5.73% in the last 52 weeks. The beta is 1.51, so Certara's price volatility has been higher than the market average.Third Quarter Highlights: Revenue was $85.6 million, PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023.Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%.Insiders trading at Certara. Over the last 4 years, insiders at Certara have traded over $2,047,095,989 worth of Certara stock and bought 97,245 units worth $1,908,085 . The most active insiders traders include Avatar Parent L.P.Eqt Avata..., James E Iii Cashman, and Mason P Slaine.On average, Certara executives and independent …Nov 29, 2023 · Certara, Inc. Stock price Equities CERT US15687V1098 Software Market Closed - Nasdaq ... Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business.

PRINCETON, N.J.– March 29, 2021 –Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 11,500,000 shares of its common stock by certain existing stockholders at a public offering price of $25.00 per share. The closing includes 1,500,000 shares sold upon full ...Here are 5 tips to streamline developing a detailed SOC that will help relieve some of the last-minute stress: 1. During the kickoff meeting, ask your regulatory affairs representative whether a detailed SOC is required. Frequently, a high-level overview of changes and the rationale for these changes is sufficient.

The new Simcyp Discovery Simulator is an intuitive PBPK software that delivers confidence in decision-making during the pre-Investigational New Drug (IND) Application and translational stages. Derived from the gold-standard Simcyp Simulator, Simcyp Discovery advances and accelerates small molecule discovery and development.Certara Stock Price, News & Analysis (NASDAQ:CERT) $14.64 +0.23 (+1.60%) (As of 12/1/2023 ET) Compare Today's Range $14.12 $14.67 50-Day Range …A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a price target for 20.00 expecting CERT to rise to within ...Dr Feehery owns over 36,580 units of Certara stock worth over $42,522,670 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara. Wallmine is a …With a price of $14.6 and a GuruFocus Value of $25.18, the stock has a price-to-GF-Value ratio of 0.58. Story continues Insider Sell: Leif Pedersen Sells 51,224 Shares of Certara Inc (CERT)Certara stock drops after biotech software company misses profit target. Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday …What is the target price for Certara (CERT) stock? A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a ...OPGN | Complete OpGen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Aug 12, 2022 · Certara became a member of the Nasdaq after an upsized initial public offering of its 29,055,000 shares of Class A common stock at $23 per share. Through the IPO, the company raised $316.3 million ...

As of now, Certara’s stock opened at $18.19 on Friday, with a market cap of $2.91 billion. The company has a price-to-earnings ratio of 202.11 and a price-to-earnings-growth ratio of 0.96, indicating the market’s confidence in its future growth potential. Certara’s beta stands at 1.58, reflecting its sensitivity to market volatility.

Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.

Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.OPGN | Complete OpGen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.1.90%. $360.63M. Adtran Networks SE. 0.50%. €1.02B. CIEN | Complete Ciena Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Specialized modules are: Simcyp Pediatric. Simcyp® Pediatric Simulator is the industry’s most sophisticated technology for modeling drug performance and determining dosing in neonates, infants, and children. The Simulator contains extensive libraries on demographics, developmental physiology, and the ontogeny of drug elimination pathways.Get the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry.Inclisiran is a novel N-acetylgalactosamine (GalNAc) conjugated small-interfering ribonucleic acid (siRNA) therapy designed to specifically target proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA in the liver for the treatment of hypercholesterolemia.Certara share price went down by -16.68% last month. The next quarterly earnings date for Certara is scheduled on November 7, 2023. Certara's next ex-dividend date is August 20, 2023.Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.John Gallagher CERT stock SEC Form 4 insiders trading. John has made over 9 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 5,746 units of CERT stock worth $437,730 on 27 February 2018.. The largest trade John's ever made was exercising 5,746 units of Certara stock …

The new Simcyp Discovery Simulator is an intuitive PBPK software that delivers confidence in decision-making during the pre-Investigational New Drug (IND) Application and translational stages. Derived from the gold-standard Simcyp Simulator, Simcyp Discovery advances and accelerates small molecule discovery and development.Certara stock has received a consensus rating of buy. The average rating score is and is based on 20 buy ratings, 10 hold ratings, and 0 sell ratings. What was the 52-week low for Certara stock?Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability …Instagram:https://instagram. spxefinancial advice onlinebest suv ever madeoil companies stock The estimated Net Worth of Richard M. Traynor is at least $10.2 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,562,422 and over the last 2 years he sold CERT stock worth over $5,603,360. consumer defensive stockhow much is 1964 half dollar worth Real time Certara (CERT) stock price quote, stock graph, news & analysis. tesla y inventory Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock ... Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Latest Software and Certara Inc, Schrodinger Inc Stock News. As of November 22, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $426.2 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price ...